REG - Arcontech Group PLC - Result of AGM <Origin Href="QuoteRef">ARC.L</Origin>

ArcontechAnnouncement

27/09/2017 17:25

RNS Number : 0198S
Arcontech Group PLC
27 September 2017
AorTech International plc
("AorTech"or the "Company")
Result of AGM
AorTech International plc (AIM: AOR), the biomaterials and medical device IP company, is pleased to announce that at the Annual General Meeting held today, all the resolutions were duly passed.
For further information contact:
AorTech International plc
Eddie McDaid, Chief Executive Tel: +44 (0)7802 920869 
AorTech International plc
Bill Brown, Chairman  Tel: +44 (0)7730 718296
finnCapLimited
Jonny Franklin-Adams / Giles Rolls  Tel: +44 20 7220 0500
About AorTech:
AorTech has developed biostable, implantable polymers, including Elast-Eon and ECSil the world's leading long-term implantable co-polymers, now manufactured on their behalf by Biomerics LLC in Utah, USA. With several million implants and seven years of successful clinical use, AorTech polymers are being developed andused in cardiology and urological applications, including pacing leads, cardiac cannulae, stents and neuro stimulation devices. Devices manufactured from AorTech polymers have numerous US FDA PMA approvals, 510k's, CE Marks, Australian TGA and Japanese Ministry of Health approvals.
Elast-Eon and ECSil's biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. These polymers can be processed using conventional thermoplastic extrusion and moulding techniques. A range of materials in a variety of application-specific formulations for use in medical devices and components are available.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
RAGOKODBABKDBCB